Semax & NA-Semax Amidate

Common side effects:

• Mild nasal irritation from intranasal administration
• Temporary headache or pressure
• Slight increase in heart rate
• Mild insomnia if taken late in the day
• Dry mouth

Rare or serious side effects:

• Severe allergic reactions or anaphylaxis
• Significant blood pressure fluctuations
• Paradoxical anxiety or agitation
• Olfactory nerve irritation

Neurotrophic modulation drives the primary mechanism of the Semax & NA-Semax Amidate peptide within the central nervous system. Upon intranasal administration, the peptide rapidly crosses the blood-brain barrier to stimulate the expression of Brain-Derived Neurotrophic Factor (BDNF) and TrkB receptors. This upregulation promotes neuronal survival, enhances synaptic plasticity, and facilitates cognitive processes like learning and memory.

Enkephalinase inhibition represents another critical pathway for Semax & NA-Semax Amidate benefits. The peptide prevents the breakdown of endogenous enkephalins, which are neuromodulators involved in pain perception, stress response, and mood regulation. Additionally, it influences neuro-immune interactions and protects against oxidative stress during cerebral ischemia Tarasov et al., 2018.

Soviet-era development marks the origin of Semax, which was synthesized in the late 1970s and 1980s by the Institute of Molecular Genetics at the Russian Academy of Sciences. Researchers designed it as a synthetic analogue of the adrenocorticotropic hormone (ACTH) fragment 4-10, specifically modified to lack hormonal activity while retaining potent neurotropic effects. It was officially approved in Russia in the 1990s for treating stroke, cognitive disorders, and optic nerve diseases.

Chemical evolution led to the creation of NA-Semax Amidate, an advanced iteration designed to improve the peptide's stability and blood-brain barrier permeability. The addition of an N-acetyl group and a C-terminal amide group protects the peptide from rapid enzymatic degradation. Despite widespread clinical use in Russia, the Semax & NA-Semax Amidate peptide remains strictly a research-only chemical in the United States and is not approved by the FDA for human consumption.